98 related articles for article (PubMed ID: 1481987)
1. Chromogenic redox assay for beta-lactamases yielding water-insoluble products. I. Kinetic behavior and redox chemistry.
Bieniarz C; Young DF; Cornwell MJ
Anal Biochem; 1992 Dec; 207(2):321-8. PubMed ID: 1481987
[TBL] [Abstract][Full Text] [Related]
2. Chromogenic redox assay for beta-lactamases yielding water-insoluble products. II. Heterogeneous sandwich assay for hCG.
Bieniarz C; Cornwell MJ; Young DF
Anal Biochem; 1992 Dec; 207(2):329-34. PubMed ID: 1481988
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
4. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
[TBL] [Abstract][Full Text] [Related]
5. A rapid-kinetic study of the class C beta-lactamase of Enterobacter cloacae 908R.
Monnaie D; Virden R; Frère JM
FEBS Lett; 1992 Jul; 306(2-3):108-12. PubMed ID: 1633864
[TBL] [Abstract][Full Text] [Related]
6. Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
Liu R; Teo W; Tan S; Feng H; Padmanabhan P; Xing B
Analyst; 2010 May; 135(5):1031-6. PubMed ID: 20419253
[TBL] [Abstract][Full Text] [Related]
7. Simple assay of beta-lactamase with agar medium containing a chromogenic cephalosporin, pyridinium-2-azo-p-dimethylaniline chromophore (PADAC).
Kobayashi S; Arai S; Hayashi S; Sakaguchi T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1040-5. PubMed ID: 3263833
[TBL] [Abstract][Full Text] [Related]
8. A chromogenic cephalosporin for β-lactamase inhibitor screening assays.
Yu S; Vosbeek A; Corbella K; Severson J; Schesser J; Sutton LD
Anal Biochem; 2012 Sep; 428(2):96-8. PubMed ID: 22709853
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and mechanism of the serine beta-lactamase catalyzed hydrolysis of depsipeptides.
Govardhan CP; Pratt RF
Biochemistry; 1987 Jun; 26(12):3385-95. PubMed ID: 3115289
[TBL] [Abstract][Full Text] [Related]
10. Modifying the specificity and activity of the Enterobacter cloacae P99 beta-lactamase by mutagenesis within an M13 phage vector.
Siemers NO; Yelton DE; Bajorath J; Senter PD
Biochemistry; 1996 Feb; 35(7):2104-11. PubMed ID: 8652552
[TBL] [Abstract][Full Text] [Related]
11. Role of residue Lys315 in the mechanism of action of the Enterobacter cloacae 908R beta-lactamase.
Monnaie D; Dubus A; Cooke D; Marchand-Brynaert J; Normark S; Frère JM
Biochemistry; 1994 May; 33(17):5193-201. PubMed ID: 8172894
[TBL] [Abstract][Full Text] [Related]
12. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of a rapid detection method for broad-spectrum beta-lactamases using a chromogenic cephalosporin].
Yagüe A; Rodríguez JC; Sandvang D; Ruiz M; Royo G
Rev Esp Quimioter; 2006 Jun; 19(2):185-6. PubMed ID: 16964336
[No Abstract] [Full Text] [Related]
14. CENTA as a chromogenic substrate for studying beta-lactamases.
Bebrone C; Moali C; Mahy F; Rival S; Docquier JD; Rossolini GM; Fastrez J; Pratt RF; Frère JM; Galleni M
Antimicrob Agents Chemother; 2001 Jun; 45(6):1868-71. PubMed ID: 11353639
[TBL] [Abstract][Full Text] [Related]
15. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals.
Levison ME; Mailapur YV; Pradhan SK; Jacoby GA; Adams P; Emery CL; May PL; Pitsakis PG
Clin Infect Dis; 2002 Dec; 35(12):1551-4. PubMed ID: 12471576
[TBL] [Abstract][Full Text] [Related]
16. A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.
Harding FA; Liu AD; Stickler M; Razo OJ; Chin R; Faravashi N; Viola W; Graycar T; Yeung VP; Aehle W; Meijer D; Wong S; Rashid MH; Valdes AM; Schellenberger V
Mol Cancer Ther; 2005 Nov; 4(11):1791-800. PubMed ID: 16276001
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam.
Shapiro AB
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971872
[TBL] [Abstract][Full Text] [Related]
18. Mutation of serine residue 318 in the class C beta-lactamase of Enterobacter cloacae 908R.
Jacobs C; Dubus A; Monnaie D; Normark S; Frère JM
FEMS Microbiol Lett; 1992 Apr; 71(1):95-100. PubMed ID: 1624116
[TBL] [Abstract][Full Text] [Related]
19. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases.
Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI
J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108
[TBL] [Abstract][Full Text] [Related]
20. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
Cai JC; Zhou HW; Chen GX; Zhang R
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
